France· FR:62252467
MELPHALAN SUN 50 mg, poudre et solvant pour solution injectable/pour perfusion
A melphalan product containing chlorhydrate de melphalan, registered in France by SUN PHARMACEUTICAL INDUSTRIES EUROPE (PAYS BAS). The same ATC class is registered in 17 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Melphalan is registered in 17 of 19 countries.
Countries holding a registration under ATC L01AA03 (melphalan), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 10 of them publish a price we can compare per daily dose
Melphalan · ATC L01AA03
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of melphalan costs, country by country.
Normalised to the WHO defined daily dose (2 mg), the median price runs from $0.79 in Italy to $3.83 in Switzerland — a ×4.8 gap.
- France: $0.89 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Melphalan · price per daily dose (2 mg)
USD · FX 28 Sept 2026
- CH Switzerland$3.83
- FR France$0.89
- IT Italy$0.79
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE DE MELPHALAN
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES EUROPE (PAYS BAS)
- Country
- France (FR)
- ATC code
- L01AA03
- ATC class
- Melphalan
- Defined daily dose
- 2 mg, O
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009301595521 flacon de poudre de 15 mL (verre) + 1 flacon de solvant de 10 mL (verre)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
242 interactions on record for melphalan.
Graded by severity as the source publishes them — 32 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Melphalan · interactions on record
242 records
- 32 severe
- 100 moderate
- 25 minor
- 85 info
Most severe, free to view
- Nalidixic acidJ01MB02severe
- ThiotepaL01AC01severe
- CladribineL01BB04severe
- Talimogene laherparepvecL01XL02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Melphalan in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsAlkeran 50 mg Infuus, poeder en oplosmiddel voor oplossing voor infusieAspen Pharma Trading Limited
- United KingdomAlkeran 2mg tabletsAspen Pharma Trading Ltd
- GermanyAlkeranAspen Pharma Trading Limited
- SpainALKERAN 2 MG COMPRIMIDOS RECUBIERTOS CON PELICULAAspen Pharma Trading Limited
- FinlandAlkeranParanova Oy
- SwedenAlkeran 2 mg Filmdragerad tablettAspen Pharma Trading Limited
- United StatesEVOMELAAcrotech Biopharma Inc
- IrelandAlkeran 2 mg Film-coated TabletsAspen Pharma Trading Limited
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Alkeran, Melphalan Hikma
- Belgium · Alkeran, Melfalan Tillomed
- Cyprus · Melfalan Tillomed
- Czechia · Alkeran, Melphalan Zentiva
- Germany · Alkeran, Melphalan
- Denmark · Alkeran, Melphalan Macure
- Estonia · Alkeran
- Spain · Alkeran, Melfalán Aspen
- Finland · Alkeran, Melphalan Macure
- United Kingdom (Northern Ireland) · Melphalan, Melphalan Accord-Uk
- Greece · Demephan, Melphalan Tillomed
- Croatia · Melfalan Pliva, Melfalan Tillomed
- Hungary · Melphalan Teva, Melphalan Zentiva
- Ireland · Alkeran, Melphalan Tillomed
- Iceland · Alkeran, Phelinun
- Italy · Alkeran, Melfalan Hikma
- Liechtenstein · Phelinun
- Lithuania · Alkeran, Melphalan Zentiva
- Luxembourg · Alkeran, Melphalan Aqvida
- Latvia · Alkeran, Melphalan Tillomed
- Netherlands · Alkeran, Melfalan Amarox
- Norway · Alkeran, Melphalan Macure
- Poland · Alkeran, Melphalan Zentiva
- Portugal · Alkeran, Melfalano Eugia
- Romania · Alkeran, Melfalan Teva
- Sweden · Alkeran, Melfalan Sun
- Slovenia · Alkeran, Melfalan Teva
- Slovakia · Alkeran, Melphalan Zentiva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0df0a2be-2fc1-482f-9a70-95ecb9955828 GET /v1/drugs/0df0a2be-2fc1-482f-9a70-95ecb9955828?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62252467",
"date_amm": "2018-09-21",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "CHLORHYDRATE DE MELPHALAN",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre et solvant pour solution injectable pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about melphalan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.